These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33872106)

  • 1. Pediatric Glial Tumors.
    Viaene AN; Santi M; Hawkins C
    Pediatr Dev Pathol; 2022; 25(1):46-58. PubMed ID: 33872106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
    Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM
    Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates in Pediatric Glioma Pathology.
    Hakar MH; Wood MD
    Surg Pathol Clin; 2020 Dec; 13(4):801-816. PubMed ID: 33183734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
    Malzkorn B; Reifenberger G
    Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histomolecular diagnosis of glial and glioneuronal tumours].
    Métais A; Rousseau A
    Ann Pathol; 2021 Apr; 41(2):137-153. PubMed ID: 33712303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
    Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult Diffuse Astrocytic and Oligodendroglial Tumors.
    Gestrich CK; Couce ME; Cohen ML
    Neurosurgery; 2021 Oct; 89(5):737-749. PubMed ID: 33611566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
    Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
    Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric low-grade gliomas: implications of the biologic era.
    Packer RJ; Pfister S; Bouffet E; Avery R; Bandopadhayay P; Bornhorst M; Bowers DC; Ellison D; Fangusaro J; Foreman N; Fouladi M; Gajjar A; Haas-Kogan D; Hawkins C; Ho CY; Hwang E; Jabado N; Kilburn LB; Lassaletta A; Ligon KL; Massimino M; Meeteren SV; Mueller S; Nicolaides T; Perilongo G; Tabori U; Vezina G; Warren K; Witt O; Zhu Y; Jones DT; Kieran M
    Neuro Oncol; 2017 Jun; 19(6):750-761. PubMed ID: 27683733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ependymal Tumors.
    Santi M; Viaene AN; Hawkins C
    Pediatr Dev Pathol; 2022; 25(1):59-67. PubMed ID: 35168420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.
    Kleinschmidt-DeMasters BK; Mulcahy Levy JM
    Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of H3 K27M mutations in adult midline gliomas.
    Ebrahimi A; Skardelly M; Schuhmann MU; Ebinger M; Reuss D; Neumann M; Tabatabai G; Kohlhof-Meinecke P; Schittenhelm J
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):839-850. PubMed ID: 30610375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.
    Aboian MS; Tong E; Solomon DA; Kline C; Gautam A; Vardapetyan A; Tamrazi B; Li Y; Jordan CD; Felton E; Weinberg B; Braunstein S; Mueller S; Cha S
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1804-1810. PubMed ID: 31694820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
    Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M
    J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic classification of gliomas.
    Perry A; Wesseling P
    Handb Clin Neurol; 2016; 134():71-95. PubMed ID: 26948349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
    Perez A; Huse JT
    Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the classification and treatment of pediatric brain tumors.
    Fangusaro J; Bandopadhayay P
    Curr Opin Pediatr; 2021 Feb; 33(1):26-32. PubMed ID: 33278109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas.
    Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Ahn SS; Chang JH; Kim SH
    J Magn Reson Imaging; 2023 Sep; 58(3):690-708. PubMed ID: 37069764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology and clinical implications of diffuse glioma.
    Chai R; Fang S; Pang B; Liu Y; Wang Y; Zhang W; Jiang T
    Chin Med J (Engl); 2022 Dec; 135(24):2914-2925. PubMed ID: 36728558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.